The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Kronos Bio Inc (NASDAQ: KRON) was $0.85 for the day, down -0.01% from the previous closing price of $0.85. In other words, the price has decreased by -$0.01 from its previous closing price. On the day, 0.67 million shares were traded. KRON stock price reached its highest trading level at $0.8579 during the session, while it also had its lowest trading level at $0.845.
Ratios:
Our analysis of KRON’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 8.32 and its Current Ratio is at 8.32. In the meantime, Its Debt-to-Equity ratio is 0.23 whereas as Long-Term Debt/Eq ratio is at 0.20.
On November 14, 2024, Piper Sandler Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $6 to $1.
On September 14, 2022, Berenberg started tracking the stock assigning a Buy rating and target price of $12.Berenberg initiated its Buy rating on September 14, 2022, with a $12 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 27 ’24 when BISCHOFBERGER NORBERT W bought 410,848 shares for $1.17 per share. The transaction valued at 478,843 led to the insider holds 10,597,468 shares of the business.
BISCHOFBERGER NORBERT W bought 204,670 shares of KRON for $254,957 on Jun 28 ’24. The PRESIDENT & CEO now owns 10,802,138 shares after completing the transaction at $1.25 per share. On Jun 10 ’24, another insider, BISCHOFBERGER NORBERT W, who serves as the PRESIDENT & CEO of the company, bought 1,378,901 shares for $0.88 each. As a result, the insider paid 1,208,469 and bolstered with 5,749,395 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KRON now has a Market Capitalization of 51283732 and an Enterprise Value of -58203288. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.20 while its Price-to-Book (P/B) ratio in mrq is 0.46. Its current Enterprise Value per Revenue stands at -6.919 whereas that against EBITDA is 0.618.
Stock Price History:
Over the past 52 weeks, KRON has reached a high of $1.60, while it has fallen to a 52-week low of $0.69. The 50-Day Moving Average of the stock is -10.20%, while the 200-Day Moving Average is calculated to be -19.47%.
Shares Statistics:
KRON traded an average of 92.88K shares per day over the past three months and 178320 shares per day over the past ten days. A total of 58.95M shares are outstanding, with a floating share count of 38.65M. Insiders hold about 35.95% of the company’s shares, while institutions hold 24.14% stake in the company. Shares short for KRON as of 1730332800 were 527682 with a Short Ratio of 5.68, compared to 1727654400 on 714171. Therefore, it implies a Short% of Shares Outstanding of 527682 and a Short% of Float of 1.15.
